Evidence map›Paper›PMID 35204526›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Computer-Aided Assessment of Melanocytic Lesions by Means of a Mitosis Algorithm.

Bart Sturm, David Creytens, Jan Smits, Ariadne H A G Ooms, Erik Eijken, Eline Kurpershoek, Heidi V N Küsters-Vandevelde, Carla Wauters, Willeke A M Blokx, Jeroen A W M van der Laak

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Bart SturmDepartment of Pathology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.ORCID 0000-0002-9841-1566
David CreytensDepartment of Pathology, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0002-6064-1673
Jan SmitsPathan B.V., 3045 PM Rotterdam, The Netherlands.
Ariadne H A G OomsPathan B.V., 3045 PM Rotterdam, The Netherlands.
Erik EijkenLaboratory for Pathology Oost Nederland (LabPON), 7550 AM Hengelo, The Netherlands.
Eline KurpershoekPathan B.V., 3045 PM Rotterdam, The Netherlands.
Heidi V N Küsters-VandeveldeDepartment of Pathology, Canisius Wilhelmina Hospital, 6500 GS Nijmegen, The Netherlands.ORCID 0000-0002-1012-941X
Carla WautersDepartment of Pathology, Canisius Wilhelmina Hospital, 6500 GS Nijmegen, The Netherlands.
Willeke A M BlokxDivision Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands.ORCID 0000-0002-4647-8830
Jeroen A W M van der LaakDepartment of Pathology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
PathoFinder (Netherlands) · NLCanisius-Wilhelmina Ziekenhuis · NLGhent University Hospital · BELinköping University · SEOntwikkelingsmaatschappij Oost Nederland · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing number of pathology laboratories are now fully digitised, using whole slide imaging (WSI) for routine diagnostics. WSI paves the road to use artificial intelligence (AI) that will play an increasing role in computer-aided diagnosis (CAD). In melanocytic skin lesions, the presence of a dermal mitosis may be an important clue for an intermediate or a malignant lesion and may indicate worse prognosis. In this study a mitosis algorithm primarily developed for breast carcinoma is applied to melanocytic skin lesions. This study aimed to assess whether the algorithm could be used in diagnosing melanocytic lesions, and to study the added value in diagnosing melanocytic lesions in a practical setting. WSI's of a set of hematoxylin and eosin (H&E) stained slides of 99 melanocytic lesions (35 nevi, 4 intermediate melanocytic lesions, and 60 malignant melanomas, including 10 nevoid melanomas), for which a consensus diagnosis was reached by three academic pathologists, were subjected to a mitosis algorithm based on AI. Two academic and six general pathologists specialized in dermatopathology examined the WSI cases two times, first without mitosis annotations and after a washout period of at least 2 months with mitosis annotations based on the algorithm. The algorithm indicated true mitosis in lesional cells, i.e., melanocytes, and non-lesional cells, i.e., mainly keratinocytes and inflammatory cells. A high number of false positive mitosis was indicated as well, comprising melanin pigment, sebaceous glands nuclei, and spindle cell nuclei such as stromal cells and neuroid differentiated melanocytes. All but one pathologist reported more often a dermal mitosis with the mitosis algorithm, which on a regular basis, was incorrectly attributed to mitoses from mainly inflammatory cells. The overall concordance of the pathologists with the consensus diagnosis for all cases excluding nevoid melanoma (

Indexed as

computer-aided diagnosismelanomamitosis algorithmnevoid melanomaWSI

Identifiers

PMID35204526
PMCPMC8871065
OpenAlexW4211247273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.